CORC

在结果中检索

CORC

浏览/检索结果: 共222条，第1-10条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Recent Developments in Chiral Unitary Theory and Triangle Singularities Involving Baryons 会议论文
作者:  Oset, E.;  Bayar, M.;  Aceti, F.;  Guo, F. K.;  Debastiani, V. R.
收藏  |  浏览/下载：30/0  |  提交时间：2018/08/20
Extended-Field Intensity Modulated Radiation Therapy (EF-IMRT) and Intra-Cavitary Brachytherapy Combined with Chemotherapy in Cervical Cancer: A Multicenter-Clinical Trial 会议论文
作者:  Zhu, H.;  Hu, K.;  Ma, J.;  Zhang, F.;  Wei, L.
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Zhang, H.;  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Targeting Established Lung Cancer Through Combination of DNT Cellular Therapy with PD1 Checkpoint Blockade 会议论文
作者:  Fang, L.;  Ly, D.;  Liu, W.;  Wang, S.;  Lee, J.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Mutation status and targeted therapeutic efficacy of advanced non-small cell lung cancer: A real-world study of NSCLC in China (preCAPTRA-LUNG) 会议论文
作者:  Liang, H.;  Song, X.;  Zhang, Y.;  Zhang, S.;  Li, F.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Zhang, Q.;  Xu, B.;  Zhang, Q.;  Sun, T.;  Li, W.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
hASCs-derived exosomes rescuing rats with acute liver failure by releasing IncRNA H19 会议论文
作者:  Jin, Y.;  Li, H.;  Wang, X.;  Chen, C.;  Fu, Q.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Xu, B.;  Luk, A.;  Liu, S.;  Jiang, W.;  Liu, E.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
The NELSON Triage Algorithm Applied to a Chinese Biopsied Population: A Pilot Study 会议论文
作者:  Yang, D.;  Beaumont, H.;  Hu, J.;  Wang, N.;  Li, P.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of Chinese chronic hepatitis B predominantly genotype B or C: results at week 240 会议论文
作者:  Xu, J. -H.;  Jing, C. -D.;  Chen, X. -F.;  Wang, S.;  Zeng, Z.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace